Search Results
Abstracts
Assessment of HCV screening and linkage to care modalities within the Georgia’s national Hepatitis C elimination program and designing the most optimal models for reaching the elimination targets
A. Abutidze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Prevention of STIs: The Role of Doxy-PEP | Deniz Gökengin
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
Transmitted Drug Resistance to Integrase Based First-line HIV Antiretroviral Treatment in the MeditRes HIV Collaboration - Federico Garcia
Presented at:
International Workshop on HIV Transmission 2020
Slidesets
Designing Clinical Trials: Highlights & Tips - Andrew Hill, MD
Presented at:
Spanish HIV Clinical Forum 2016
Abstracts
Clinical Characteristics of Newly Diagnosed Individuals with HIV Infection in a University Hospital
R. Boonyawairote
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Slidesets
Linking “intended use” to evidence needed for bringing a biomarker to market- John Sninsky, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
E-Posters
Baseline gut microbiome dysbiosis predicts gut microbiome response to ART co-trimoxazole treatment in HIV-positive individuals in rural and urban Zimbabwe - Alessandro Lazzaro, MD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020